Recombinant Methanosarcina barkeri Putative Cobalt Transport Protein CbiM 2 (cbiM2) is a key component of the cobalt uptake machinery in the archaeon Methanosarcina barkeri, a methanogen notable for its metabolic versatility. This protein is part of the energy-coupling factor (ECF) transporter family, specifically classified as a group-I cobalt transporter. Its recombinant form enables biochemical and structural studies critical for understanding microbial metal homeostasis and methanogenic pathways .
CbiM2 functions as the substrate-binding subunit (EcfS) of the CbiMNQO transporter complex, a group-I ECF transporter critical for high-affinity cobalt uptake . Key findings include:
ATPase Activation: CbiM stimulates ATP hydrolysis by the CbiQO module (basal activity: , ) independent of cobalt binding .
Substrate Specificity: The transporter exhibits >90% specificity for cobalt over nickel, attributed to residues in the L1 loop (e.g., His2 and His69) that form the substrate-binding pocket . Mutations at these residues abolish transport activity .
Methanogenesis: Cobalt is essential for synthesizing vitamin B derivatives, which are cofactors in methyltransferases involved in methane production .
Energy Conservation: The CbiMNQO transporter supports intracellular hydrogen cycling, a unique energy-conservation strategy in M. barkeri during acetate metabolism .
Gene Cluster: cbiM2 is part of a cobalt-regulated operon adjacent to B-dependent enzymes .
Conservation: Homologs of CbiM are widespread in prokaryotes, particularly in microbes reliant on cobalt for anaerobic metabolism .
Recombinant CbiM2 is used to:
Characterize cobalt transport kinetics and inhibition.
Creative Biomart. Recombinant Full Length Methanosarcina barkeri Putative Cobalt Transport Protein CbiM 2 .
Mand et al. (2018). The Hydrogen Economy of Methanosarcina barkeri .
Bao et al. (2017). Structure and Mechanism of a Group-I Cobalt ECF Transporter .
Reed et al. (2006). Genome-Scale Metabolic Model of Methanosarcina barkeri .
Kulkarni et al. (2017). Functional Characterization of CbiMNQO .
Rodionov et al. (2006). Comparative Genomic Analysis of Nickel/Cobalt Transporters .
KEGG: mba:Mbar_A2145
STRING: 269797.Mbar_A2145
CbiM2 functions as a putative transmembrane cobalt transport protein that facilitates the uptake of cobalt ions required for the biosynthesis of vitamin B12 derivatives. M. barkeri contains the complete anaerobic pathway for vitamin B12 derivative synthesis, which is essential for its methanogenic metabolism . The genome-scale metabolic model (iAF692) of M. barkeri confirms the presence of this biosynthetic pathway among the organism's 619 total reactions . Cobalt transport represents a critical metabolic function as cobalt is a central component of the corrin ring structure in vitamin B12, which serves as a cofactor for several methyltransferases in the methanogenic pathway.
CbiM2 supports methanogenesis indirectly by enabling vitamin B12 biosynthesis. M. barkeri is capable of growing on all three major methanogenic substrates (methanol, acetate, and H2/CO2) as well as pyruvate . The metabolic reconstruction model iAF692 identifies 23 reactions in the methanogenic pathway associated with 125 distinct genes . Vitamin B12 derivatives function as cofactors for methyltransferases involved in these pathways, particularly in methanol and acetate utilization. By facilitating cobalt transport, CbiM2 contributes to the synthesis of these essential cofactors, making it an indirect but critical component of M. barkeri's methanogenic capacity and versatile substrate utilization.
The cbiM2 gene is located within the 4.8 Mb genome of M. barkeri, which contains 5,072 ORFs (Open Reading Frames) . While the precise genomic context is not explicitly detailed in current research, the gene is part of the 692 metabolic genes identified in the iAF692 model that are associated with 509 reactions . The genomic organization likely reflects the biochemical relationship between cobalt transport and vitamin B12 biosynthesis. In typical prokaryotic systems, cobalt transporter genes are often organized in operons containing additional components of the transport system (such as CbiQ, CbiO, and CbiN), suggesting similar organization may exist for cbiM2 in M. barkeri.
Confirming CbiM2's role as a cobalt transporter requires multiple experimental approaches. The iAF692 metabolic model of M. barkeri has demonstrated high predictive accuracy for growth phenotypes of both wild-type and mutant strains (13 out of 14 cases showed agreement between model predictions and experimental data) . Similar experimental validation approaches could be applied to characterize CbiM2 function, including:
Gene deletion studies to observe effects on cobalt uptake and vitamin B12 biosynthesis
Heterologous expression in cobalt transport-deficient strains
Radioactive cobalt (60Co) uptake assays
Metal binding assays using purified protein
Growth studies under varying cobalt concentrations
Expressing recombinant CbiM2 presents challenges due to its archaeal origin and membrane protein nature. The most effective approaches include:
E. coli-based expression systems:
BL21(DE3) strains with archaeal codon optimization
C41/C43 strains specifically designed for membrane protein expression
Co-expression with archaeal chaperones to facilitate proper folding
Archaeal expression hosts:
Homologous expression in M. barkeri (more technically challenging)
Heterologous expression in related archaeal species with established genetic tools
Expression optimization parameters:
Lower induction temperatures (16-25°C) to reduce inclusion body formation
Extended expression periods with lower inducer concentrations
Specialized media formulations with defined cobalt concentrations
The metabolic reconstruction of M. barkeri indicates multiple enzyme complexes (65 reported in the model) , suggesting that CbiM2 may function as part of a multicomponent transport system, which would influence expression strategy selection.
Purification of membrane transport proteins like CbiM2 requires specialized approaches:
| Purification Step | Recommended Methodology | Considerations |
|---|---|---|
| Membrane isolation | Differential centrifugation | Requires careful optimization for archaeal membranes |
| Solubilization | Detergent screening (DDM, LMNG, MNG-3) | Detergent selection critical for maintaining function |
| Affinity purification | IMAC using His-tag | Tag position (N- or C-terminal) may affect function |
| Size exclusion | Superdex 200 | Detergent micelle contributes to apparent size |
| Functional verification | Cobalt binding assays | Essential to confirm activity post-purification |
For structural studies, additional purification considerations include detergent exchange, lipid supplementation, and assessment of conformational homogeneity. The presence of 558 distinct metabolites in the M. barkeri metabolic network suggests that specific cofactors or small molecules may be important for CbiM2 stability during purification.
Functional characterization of CbiM2's cobalt transport capabilities requires multiple complementary approaches:
Liposome reconstitution assays:
Purified CbiM2 reconstituted into liposomes with defined lipid composition
Establish ion gradients relevant to archaeal physiology
Measure cobalt uptake using atomic absorption spectroscopy or ICP-MS
Include control liposomes without protein to account for passive diffusion
Metal binding characterization:
Isothermal titration calorimetry (ITC) to determine binding affinity and stoichiometry
Fluorescence spectroscopy with metal-sensitive fluorophores
Equilibrium dialysis with radioactive cobalt
Competitive binding assays with other divalent metals
Structure-function analysis:
Site-directed mutagenesis of predicted metal-binding residues
Assessment of transport activity in reconstituted systems
Correlation with structural data when available
The genome-scale metabolic model of M. barkeri has been successfully used to predict phenotypes under different genetic and environmental conditions , suggesting that similar approaches could be used to predict the impact of manipulating cobalt transport on cellular metabolism.
Energy conservation is a critical aspect of methanogenic metabolism. The iAF692 model of M. barkeri specifically examined "the efficiency of the energy-conserving reactions in the methanogenic pathway, specifically the Ech hydrogenase reaction" . While CbiM2 is not directly involved in energy conservation, its role in cobalt transport indirectly supports energy metabolism through vitamin B12-dependent reactions.
The energetics of CbiM2-mediated cobalt transport may involve:
Understanding these mechanisms requires:
Measurement of transport activity under different energetic conditions
Assessment of ATP or ion requirements for transport
Integration with the broader energy metabolism of M. barkeri
The metabolic model indicates that M. barkeri contains six energy-conserving ion translocating enzymes in its methanogenic pathway , suggesting that energy coupling is critical for the organism's metabolism and may extend to transport processes like cobalt uptake.
Cobalt limitation likely triggers regulatory responses affecting CbiM2 expression. While specific regulatory mechanisms for CbiM2 are not detailed in current research, investigation approaches include:
Transcriptional analysis under defined cobalt conditions:
RT-qPCR to measure cbiM2 mRNA levels
RNA-seq to identify co-regulated genes in the cobalt limitation response
Promoter analysis to identify regulatory elements
Proteomics approaches:
Quantitative proteomics to measure CbiM2 protein levels
Phosphoproteomics to identify post-translational modifications
Protein-protein interaction studies to identify regulatory partners
Physiological assessments:
Growth kinetics under cobalt limitation
Vitamin B12 synthesis quantification
Methanogenesis rates on different substrates
These investigations would complement the existing metabolic model, which has been used to examine substrate utilization and genetic knockouts . The model could be extended to predict cellular responses to varying cobalt availability.
Understanding the structural basis of CbiM2-mediated cobalt transport requires multi-faceted approaches:
Cryo-electron microscopy (cryo-EM):
Single-particle analysis for high-resolution structure determination
Visualization of different conformational states during transport
Particularly valuable for membrane protein complexes
X-ray crystallography:
Lipidic cubic phase crystallization for membrane proteins
Heavy atom derivatization using cobalt to identify binding sites
Crystal optimization with antibody fragments or nanobodies
Spectroscopic methods:
Electron paramagnetic resonance (EPR) for cobalt coordination analysis
Fluorescence resonance energy transfer (FRET) for conformational dynamics
Nuclear magnetic resonance (NMR) for ligand binding studies
Computational approaches:
Homology modeling based on related transporters
Molecular dynamics simulations to study ion permeation
Quantum mechanical calculations for metal coordination chemistry
The metabolic reconstruction of M. barkeri has already provided valuable insights into the organism's biochemistry , and structural studies of CbiM2 would further enhance our understanding of the molecular mechanisms underlying cobalt transport and utilization.
Systematic mutational analysis can reveal key functional regions of CbiM2:
Targeted mutagenesis approaches:
Alanine scanning of transmembrane regions
Conservative and non-conservative substitutions of predicted metal-binding residues
Chimeric proteins with homologous transporters to identify specificity determinants
Functional assays for mutant characterization:
Transport activity measurements in reconstituted systems
Metal binding assays to assess direct effects on cobalt coordination
Complementation studies in transport-deficient strains
Structure-guided mutagenesis:
Mutations based on computational structural predictions
Evolutionary conservation analysis to prioritize targets
Cross-linking studies to identify interacting residues
The iAF692 metabolic model could help predict the phenotypic consequences of disrupting cobalt transport on vitamin B12 synthesis and downstream metabolic pathways , providing context for interpreting mutational data.
The existing iAF692 genome-scale metabolic model of M. barkeri provides a foundation for integrating CbiM2 function:
Enhanced transport reaction representation:
Explicit incorporation of cobalt transport reactions
Linking transport to gene-protein-reaction (GPR) associations
Implementation of regulatory constraints based on experimental data
Flux balance analysis applications:
Prediction of growth phenotypes under varying cobalt availability
Simulation of cbiM2 deletion or overexpression effects
Identification of alternate routes for cobalt acquisition
Model validation and refinement:
Experimental testing of model predictions regarding cobalt dependence
Iterative refinement based on experimental results
Extension to include detailed vitamin B12 biosynthesis pathways
The iAF692 model has already demonstrated high predictive accuracy for methanogenic pathway mutants (13 out of 14 cases showed agreement with experimental data) , suggesting that similar approaches would be valuable for studying cobalt transport.
Comparative analysis can provide evolutionary insights into CbiM2 function:
Homology analysis across archaea:
Identification of CbiM homologs in diverse methanogenic species
Analysis of sequence conservation patterns
Correlation with methanogenic capabilities and ecological niches
Gene neighborhood analysis:
Examination of genomic context and operon structure
Identification of co-evolved components (CbiQ, CbiO, CbiN)
Horizontal gene transfer assessment
Phylogenetic reconstruction:
Evolutionary history of cobalt transporters in methanogens
Comparison with evolution of vitamin B12 biosynthesis pathways
Correlation with substrate utilization capabilities
The comparative analysis in the search results indicates that M. barkeri's metabolic network shares only 25.2% of metabolites and 12.6% of reactions with networks from other domains of life , highlighting the unique aspects of archaeal metabolism that may extend to cobalt transport systems.
Longitudinal studies of CbiM2 expression and function can reveal dynamic regulatory patterns:
Time-course experimental designs:
Monitoring cbiM2 expression during growth phase transitions
Tracking changes in response to cobalt availability fluctuations
Assessing adaptation to different methanogenic substrates
Statistical analysis approaches:
Time-series analysis methods for identifying regulatory patterns
Longitudinal data analysis to account for temporal correlations
Integration with metabolic modeling for flux predictions
Data integration strategies:
Combining transcriptomic, proteomic, and metabolomic measurements
Correlation analysis between cobalt transport, vitamin B12 synthesis, and methanogenesis
Network analysis to identify regulatory relationships
The search results mention q2-longitudinal, a software plugin for longitudinal analysis that could be adapted for analyzing time-course data , providing valuable tools for studying the dynamic regulation of CbiM2.